2018
DOI: 10.3892/ol.2018.9504
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of HDAC6 suppresses tumor cell proliferation and metastasis by inhibition of the canonical Wnt/β‑catenin signaling pathway in hepatocellular carcinoma

Abstract: Histone deacetylase 6 (HDAC6), a specific histone deacetylase family member, serves an essential role in the regulation of gene expression, cell cycle progression, autophagy and apoptosis. There are numerous reports on the function of HDAC6 in cancer. However, the specific function of HDAC6 in hepatocellular carcinoma (HCC) has yet to be revealed. In the present study, the expression of HDAC6 was revealed to be downregulated in human HCC cell lines and tissues. The aberrant activation of the canonical Wnt/β-ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
13
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 40 publications
(53 reference statements)
1
13
0
Order By: Relevance
“…Interestingly, we show that HDAC6, a deacetylase primarily localized in the cytoplasm, negatively regulates the acetylation and phosphorylation of β-catenin, i.e. positively regulates Wnt/β-catenin signaling, in agreement with previous reports (Li et al, 2008; Wang et al, 2014a) but in contrary to another study in hepatocellular carcinoma cells (Yin et al, 2018); and we find that HDAC6 is critical for the β-catenin signaling pathway to promote FMOD expression, and reveal HDAC6 as a component and regulator of the canonical Wnt/β-catenin pathway right upstream of β-catenin, and also as a direct target of Aspirin inhibition of this pathway and breast cancer (see below).…”
Section: Discussionsupporting
confidence: 92%
“…Interestingly, we show that HDAC6, a deacetylase primarily localized in the cytoplasm, negatively regulates the acetylation and phosphorylation of β-catenin, i.e. positively regulates Wnt/β-catenin signaling, in agreement with previous reports (Li et al, 2008; Wang et al, 2014a) but in contrary to another study in hepatocellular carcinoma cells (Yin et al, 2018); and we find that HDAC6 is critical for the β-catenin signaling pathway to promote FMOD expression, and reveal HDAC6 as a component and regulator of the canonical Wnt/β-catenin pathway right upstream of β-catenin, and also as a direct target of Aspirin inhibition of this pathway and breast cancer (see below).…”
Section: Discussionsupporting
confidence: 92%
“…And the regulation of WNT signaling was also researched in HCC. It was reported that HDAC6 inhibits WNT pathway to suppress cell proliferation in HCC [50]. Herein, we unmasked that lncRNA OIP5-AS1 targeted to miR-300 and enhanced HCC cell growth.…”
Section: Discussionmentioning
confidence: 94%
“…For example, a recent study (31) has described that deletion of HDAC6 in T helper 17 (Th17) cells impedes HCC growth by enhancing the production of antitumor cytokines and CD8 T cell mediated antitumor response in mice. However, other studies have shown that HDAC6 is a tumor suppressor for HCC (32)(33)(34). It is reported that low expression of HDAC6 in liver cancer specimens is highly associated with poor prognosis of HCC patients (32).…”
Section: Discussionmentioning
confidence: 99%